Healthcare sector company SNDL posted a 5.9% performance today, while the S&P 500 returned 1.2%.
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company is based in Calgary and has 580 full time employees. Its market capitalization is $600,913,517.
4 analysts are following SNDL and have set target prices ranging from $3 to $6.01 per share. On average, they have given the company a rating of buy. At today's prices, SNDL is trading -44.35% away from its average analyst target price of $4.15 per share.
Over the last year, SNDL shares have gone down by -55.2%, which represents a difference of -42.8% when compared to the S&P 500. The stock's 52 week high is $8.91 per share and its 52 week low is $1.95. SNDL has averaged free cash flows of $-156,923,333 over the last three years, with a mean growth rate of -43.3%. It is likely that the stock will keep following its current negative performance trend while the underlying business is experiencing such poor cash flows.
|Date Reported||Cash Flow from Operations ($ MM)||Capital expenditures ($ MM)||Free Cash Flow ($ MM)||YoY Growth (%)|